APA

Gustafsson A. M. E., Bäck T., Elgqvist J., Jacobsson L., Hultborn R., Albertsson P., Morgenstern A., Bruchertseifer F., Jensen H. & Lindegren S. (20120530). Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model. : Nuclear medicine and biology.

Chicago

Gustafsson Anna M E, Bäck Tom, Elgqvist Jörgen, Jacobsson Lars, Hultborn Ragnar, Albertsson Per, Morgenstern Alfred, Bruchertseifer Frank, Jensen Holger and Lindegren Sture. 20120530. Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model. : Nuclear medicine and biology.

Harvard

Gustafsson A. M. E., Bäck T., Elgqvist J., Jacobsson L., Hultborn R., Albertsson P., Morgenstern A., Bruchertseifer F., Jensen H. and Lindegren S. (20120530). Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model. : Nuclear medicine and biology.

MLA

Gustafsson Anna M E, Bäck Tom, Elgqvist Jörgen, Jacobsson Lars, Hultborn Ragnar, Albertsson Per, Morgenstern Alfred, Bruchertseifer Frank, Jensen Holger and Lindegren Sture. Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model. : Nuclear medicine and biology. 20120530.